跳到主要内容

Moelis & Co (MC) Stock Forecast 2025 - AI Price Prediction & Analysis


Moelis & Co (MC) AI Stock Price Forecast & Investment Analysis

Moelis & Co Stock Price Chart and Technical Analysis

Loading Moelis & Co interactive price chart and technical analysis...

Moelis & Co (MC) - Comprehensive Stock Analysis & Investment Research

Deep dive into Moelis & Co's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Moelis & Co, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Moelis & Co: Moelis & Co operates in the Finance sector, making it an emerging small-cap investment.

Moelis & Co (Stock Symbol: MC) is a leading company in the Finance sector , specifically operating within the Investment Advice industry.

The organization employs approximately 1324 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Moelis & Co's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Moelis & Co: With $1579M in annual revenue and 23.1% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $1579 million generating a 23.1% net profit margin .

Return on Equity (ROE): 79.3% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Moelis & Co stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Moelis & Co: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Moelis & Co stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Moelis & Co's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Moelis & Co: Strong free cash flow generation demonstrates solid operational efficiency.

Moelis & Co strategically competes in the highly dynamic Investment Advice marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $672 million annually, complemented by impressive 105.1% year-over-year cash flow growth.

The company maintains a healthy 40.8% gross margin, indicating strong pricing power and operational efficiency.

Moelis & Co (MC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Moelis & Co stock analysis.

Loading Moelis & Co comprehensive fundamental analysis and insider trading data...

Deep dive into Moelis & Co's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Moelis & Co stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Moelis & Co: With a P/E ratio of 7.55, the market sees the stock as potentially undervalued.

P/E Ratio 7.55x
Dividend Yield 5.89%
EPS $5.28
Book Value/Share $6.74
Revenue/Share $22.88
FCF/Share $4.64
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Moelis & Co converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Moelis & Co: An ROE of 79.3% demonstrates excellent shareholder value creation.

ROE 79.3%
ROA 33.6%
ROIC 56.1%
Gross Margin 40.8%
Operating Margin 32.5%
Net Margin 23.1%
EBT Margin 34.7%
Tax Rate 23.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Moelis & Co's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Moelis & Co: A current ratio of 0.44 suggests potential liquidity concerns.

Current Ratio 0.44x
Quick Ratio 0.40x
D/E Ratio 0.43x
Financial Leverage 2.51x
Working Capital $-248M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Moelis & Co's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Moelis & Co: Free cash flow of $672M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $687M
Free Cash Flow $672M
Capital Spending $-15M
OCF Growth YoY 105.1%
FCF Growth YoY 91.6%
FCF/Sales 42.6%
CapEx/Sales 1.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Moelis & Co uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Moelis & Co: An asset turnover of 1.46x demonstrates efficient asset utilization.

Asset Turnover 1.46x
Receivables Turnover 28.4x
Fixed Assets Turnover 7.1x
Days Sales Outstanding 13 days
Payables Period 15 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Moelis & Co's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Moelis & Co: With annual revenue of $1579M, Moelis & Co operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1579M
Operating Income $32M
Net Income $-15M
SG&A Expense $6M
Cost of Goods Sold $59M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 19%
Cash & Short-term Investments 12%
Total Liabilities 60%
Accounts Receivable 5%
Dividend & Shareholder Information
Dividends Per Share $2.35
Payout Ratio 44.5%
Shares Outstanding 69M

Latest Moelis & Co Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Moelis & Co (MC) stock price and investment outlook.

, source: Benzinga

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $77.75, with a high estimate of $90.00 and a low estimate of $64.00. This current average ...

, source: Seeking Alpha

Moelis & Company is an investment banking advisory firm. Current market and economic conditions suggest Moelis will struggle in the coming quarters as market activity remains low. The fundamentals of ...

Moelis & Co Competitors & Peer Analysis - Finance Sector

Comparative analysis of Moelis & Co against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAMI Unlock Forecast - 30 Days FREE Trial $M x x
AB Unlock Forecast - 30 Days FREE Trial $0M 11.6x 0.0x
ABL Unlock Forecast - 30 Days FREE Trial $652M -396.0x 1.6x
ABLLL Unlock Forecast - 30 Days FREE Trial $2473M -1421.2x 5.9x
ABLLW Unlock Forecast - 30 Days FREE Trial $78M x -4.3x
ALTI Unlock Forecast - 30 Days FREE Trial $0M -2.2x 0.0x
AMG Unlock Forecast - 30 Days FREE Trial $10352M 23.4x 3.2x
AMP Unlock Forecast - 30 Days FREE Trial $49038M 15.2x 8.1x
APAM Unlock Forecast - 30 Days FREE Trial $5938M 21.9x 15.6x
APO Unlock Forecast - 30 Days FREE Trial $139386M 41.4x 7.2x
APO-PA Unlock Forecast - 30 Days FREE Trial $72130M 21.4x 3.7x
APOS Unlock Forecast - 30 Days FREE Trial $27458M 8.2x 1.4x
ARES Unlock Forecast - 30 Days FREE Trial $114467M 246.8x 32.3x
ARES-PB Unlock Forecast - 30 Days FREE Trial $35869M 77.4x 10.1x
BAM Unlock Forecast - 30 Days FREE Trial $22352M x 10.8x
BEN Unlock Forecast - 30 Days FREE Trial $15059M 46.7x 1.2x
BRDG Unlock Forecast - 30 Days FREE Trial $2070M -43.6x 27.6x
BSIG Unlock Forecast - 30 Days FREE Trial $0M 18.8x 0.0x
BX Unlock Forecast - 30 Days FREE Trial $123068M 67.2x 15.4x
CG Unlock Forecast - 30 Days FREE Trial $21574M -285.9x 3.0x
CGABL Unlock Forecast - 30 Days FREE Trial $6378M -88.4x 1.4x
CNS Unlock Forecast - 30 Days FREE Trial $3706M 38.5x 7.3x
DBRG Unlock Forecast - 30 Days FREE Trial $2354M 43.5x 1.2x
DBRG-PH Unlock Forecast - 30 Days FREE Trial $4717M 87.2x 2.3x
DBRG-PI Unlock Forecast - 30 Days FREE Trial $4657M 86.0x 2.3x
DBRG-PJ Unlock Forecast - 30 Days FREE Trial $4646M 85.8x 2.3x
DHIL Unlock Forecast - 30 Days FREE Trial $443M 9.2x 2.6x
ENDI Unlock Forecast - 30 Days FREE Trial $95M x 4.3x
EVR Unlock Forecast - 30 Days FREE Trial $15700M 34.0x 9.5x
FHI Unlock Forecast - 30 Days FREE Trial $0M 14.4x 0.0x
GCMG Unlock Forecast - 30 Days FREE Trial $4212M 152.2x 0.0x
GCMGW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
GROW Unlock Forecast - 30 Days FREE Trial $0M 24.4x 0.0x
HKHC Unlock Forecast - 30 Days FREE Trial $3991M 37.7x 11.4x
HLI Unlock Forecast - 30 Days FREE Trial $0M 38.5x 0.0x
HLNE Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
HNNA Unlock Forecast - 30 Days FREE Trial $97M 15.8x 1.0x
HNNAZ Unlock Forecast - 30 Days FREE Trial $198M 32.4x 2.1x
ILLR Unlock Forecast - 30 Days FREE Trial $24M -4.4x -31.3x
ILLRW Unlock Forecast - 30 Days FREE Trial $24M x -4.1x
IVZ Unlock Forecast - 30 Days FREE Trial $8996M -46.3x 0.6x
JHG Unlock Forecast - 30 Days FREE Trial $6550M 16.5x 1.4x
KKR Unlock Forecast - 30 Days FREE Trial $307839M 150.1x 10.9x
KKR-PD Unlock Forecast - 30 Days FREE Trial $120725M 58.9x 4.3x
KKRS Unlock Forecast - 30 Days FREE Trial $42348M 20.7x 1.5x
KKRT Unlock Forecast - 30 Days FREE Trial $57942M 28.3x 2.1x
LAZ Unlock Forecast - 30 Days FREE Trial $6794M 21.9x 9.2x
MAAS Unlock Forecast - 30 Days FREE Trial $M x x
MC Unlock Forecast - 30 Days FREE Trial $0M 7.6x 0.0x
MGR Unlock Forecast - 30 Days FREE Trial $989M 2.2x 0.3x
MGRB Unlock Forecast - 30 Days FREE Trial $826M 1.9x 0.3x
MGRD Unlock Forecast - 30 Days FREE Trial $740M 1.7x 0.2x
MGRE Unlock Forecast - 30 Days FREE Trial $1122M 2.5x 0.4x
MORN Unlock Forecast - 30 Days FREE Trial $12263M 56.0x 17.9x
NOAH Unlock Forecast - 30 Days FREE Trial $349M x 1.6x
OAK-PA Unlock Forecast - 30 Days FREE Trial $5671M 18.4x 2.4x
OAK-PB Unlock Forecast - 30 Days FREE Trial $5692M 18.5x 2.4x
OWL Unlock Forecast - 30 Days FREE Trial $0M 149.1x 0.0x
PJT Unlock Forecast - 30 Days FREE Trial $0M 29.0x 0.0x
PX Unlock Forecast - 30 Days FREE Trial $1662M 113.9x 4.9x
RILY Unlock Forecast - 30 Days FREE Trial $90M -0.6x -0.2x
RILYG Unlock Forecast - 30 Days FREE Trial $310M -1.6x -0.6x
RILYK Unlock Forecast - 30 Days FREE Trial $626M -2.4x -1.3x
RILYL Unlock Forecast - 30 Days FREE Trial $73M -0.9x -0.2x
RILYM Unlock Forecast - 30 Days FREE Trial $766M -2.8x -1.5x
RILYN Unlock Forecast - 30 Days FREE Trial $352M -1.6x -0.7x
RILYP Unlock Forecast - 30 Days FREE Trial $80M -0.9x -0.2x
RILYT Unlock Forecast - 30 Days FREE Trial $214M -1.3x -0.4x
RILYZ Unlock Forecast - 30 Days FREE Trial $196M -1.2x -0.4x
SAMG Unlock Forecast - 30 Days FREE Trial $0M 17.9x 0.0x
STEP Unlock Forecast - 30 Days FREE Trial $52321M 109.3x 339.9x
TPG Unlock Forecast - 30 Days FREE Trial $78221M 1256.1x 78.9x
TPGXL Unlock Forecast - 30 Days FREE Trial $34327M 551.2x 34.6x
TROW Unlock Forecast - 30 Days FREE Trial $26548M 13.0x 2.5x
VALU Unlock Forecast - 30 Days FREE Trial $0M 20.7x 0.0x
VCTR Unlock Forecast - 30 Days FREE Trial $4762M 17.0x 1.9x
VRTS Unlock Forecast - 30 Days FREE Trial $1543M 10.6x 1.7x
WHG Unlock Forecast - 30 Days FREE Trial $153M 27.8x 1.3x

Frequently Asked Questions - Moelis & Co Stock Forecast

How accurate are Moelis & Co stock predictions?

Our AI model demonstrates 46% historical accuracy for MC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Moelis & Co stock price forecasts?

Our analysis considers Moelis & Co's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Moelis & Co a good investment in 2025?

Based on our AI analysis, Moelis & Co shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Moelis & Co forecasts updated?

Moelis & Co stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Moelis & Co Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Moelis & Co stock.

My Portfolio

Investment Dashboard

Loading your portfolio...